These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30076667)

  • 1. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model.
    Dietz Ostergaard S; Butler K; Ritter JM; Johnson R; Sanders J; Powell N; Lathrop G; Zaki SR; McNicholl JM; Kersh EN
    J Med Primatol; 2015 Apr; 44(2):97-107. PubMed ID: 25536296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
    Huijbregts RP; Michel KG; Hel Z
    Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
    mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
    Nasr MA; Aldous A; Daniels J; Joy C; Capozzi E; Yang M; Moriarty P; Emmanuel-Baker V; Malcolm S; Green SJ; Gomez-Lobo V; Ghosh M
    PLoS One; 2024; 19(7):e0306237. PubMed ID: 39008499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
    Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
    Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
    Butler K; Ritter J; Ellis S; Henning TR; Montague J; Zaki S; Garber D; McNicholl JM; Kersh EN
    J Med Primatol; 2015 Oct; 44(5):286-95. PubMed ID: 26238265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
    Singata-Madliki M; Lawrie TA; Balakrishna Y; d'Hellencourt FC; Hofmeyr GJ
    Reprod Health; 2021 Sep; 18(1):192. PubMed ID: 34587971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    Butler K; Ritter JM; Ellis S; Morris MR; Hanson DL; McNicholl JM; Kersh EN
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):363-71. PubMed ID: 27355414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
    Quispe Calla NE; Vicetti Miguel RD; Boyaka PN; Hall-Stoodley L; Kaur B; Trout W; Pavelko SD; Cherpes TL
    Mucosal Immunol; 2016 Nov; 9(6):1571-1583. PubMed ID: 27007679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
    Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
    AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
    J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys.
    Hild-Petito S; Veazey RS; Larner JM; Reel JR; Blye RP
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S125-30. PubMed ID: 9581896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T; Olsson SE; Gudmundson J
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.
    Kourtis AP; Haddad L; Tang J; Chinula L; Hurst S; Wiener J; Ellington S; Nelson JA; Corbett A; De Paris K; King CC; Hosseinipour M; Hoffman IF; Jamieson DJ
    Contemp Clin Trials; 2017 Jan; 52():27-34. PubMed ID: 27836505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
    Li L; Zhou J; Wang W; Huang L; Tu J; Baiamonte L; Stark M; Mills M; Hope TJ; Drobnis EZ; Quayle AJ; Schust DJ
    Reprod Biol Endocrinol; 2019 Feb; 17(1):26. PubMed ID: 30795774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
    Mugo NR; Stalter RM; Heffron R; Rees H; Scoville CW; Morrison C; Kourtis AP; Bukusi E; Beksinka M; Philip NM; Beesham I; Deese J; Edward V; Donnell D; Baeten JM;
    Clin Infect Dis; 2022 Sep; 75(4):586-595. PubMed ID: 34910143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.